BRISBANE-BASED software
firm DoseMe is targeting both
the hospital and the primary
care sectors with its easy-to-use
medications dose individualisation
tool, reports Pulse+IT.
The DoseMe system has been
optimised for a range of antibiotics,
anti-coagulants, chemotherapeutic
agents and immunosuppressants
handled by hospital pharmacies but
also in the primary care setting for
notoriously difficult to dose drugs
with a narrow therapeutic range
like warfarin, the report said.
Now being used for both clinical
and research purposes at St
Vincent’s Hospital in Sydney, the
system is also being promoted to
GPs via a partnership with Siemens
Healthcare.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jul 16
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.